◆ TICKERBASEVue interactive →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Accueil › Toutes les actions › 4901 · English version

FUJIFILM Holdings Corporation (4901)

Historique du chiffre d'affaires, des bénéfices et des flux de trésorerie d'après les états financiers officiels.

Industrials · Wall Street (États-Unis) · Dernière mise à jour : 2026-10-02

FUJIFILM Holdings Corporation provides products and services in the fields of healthcare, electronics, business innovation, and imaging in Japan, the Americas, Europe, Asia, and internationally. Its Healthcare segment offers products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment; equipment and materials for medical systems; drug discovery support, such as iPS cells; and cell culture media and reagents.

Chiffres clés

Voir les graphiques interactifs et les états complets → Modèle de valorisation (DCF) →

Compte de résultat annuel

Compte de résultat2026-03-312025-03-312024-03-312023-03-312022-03-31
Chiffre d'affaires totalJPY 3.36TJPY 3.20TJPY 2.96TJPY 2.86T—
Bénéfice brutJPY 1.37TJPY 1.30TJPY 1.19TJPY 1.14T—
Résultat opérationnel (EBIT)JPY 350.2BJPY 330.2BJPY 276.7BJPY 273.1B—
Résultat netJPY 276.7BJPY 261.0BJPY 243.5BJPY 219.4B—

Source : rapports publics de la société (SEC). Vérifiez sur SEC EDGAR avant de vous fier à tout chiffre.

Bilans, flux de trésorerie, données trimestrielles et ratios complets dans le visualiseur interactif de 4901. /companies/us/4901

Entreprises similaires

Les informations de ce site sont fournies à des fins éducatives et informatives uniquement ; elles ne constituent pas un conseil en investissement. Aucun objectif de cours ni recommandation n'est publié.

English version →Toutes les actions

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.